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Abstract 
Animal olfactory detection of human diseases has attracted an increasing amount of 
interest from researchers in recent years. Because of th  inconsistent findings reported in this 
body of research and the complexity of scent detection research, it is difficult to ascertain the 
potential value of animal detectors in operational di gnostic algorithms. We have outlined 
key factors associated with successful training and evaluation of animals for operational 
disease detection and, using these key factors as points for comparison, conducted a 
systematic review of the research in this area. Studies that were published in peer-reviewed 
outlets and that described original research evaluating nimals for detection of human 
diseases were included in the review. The majority f relevant studies have assessed dogs as 
detectors of various forms of cancer. Other researchers have targeted bacteriuria, Clostridium 
difficile, hypoglycemia, and tuberculosis. Nematodes and pouched rats were the only 
exceptions to canine detectors. Of the 28 studies meeting inclusion criteria, only 9 employed 
operationally feasible procedures. The most common threat to operational viability was the 
use of a fixed number of positive samples in each smple run. Most reports included 
insufficient information for replication or adequate evaluation of the validity of the findings. 
Therefore, we have made recommendations regarding the type of information that should be 
included when describing research in this area. The results of this systematic review suggest 
that animal detectors hold promise for certain diagnostic applications but that additional 
research evaluating operationally viable systems for ol actory detection of human diseases is 
necessary. 
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Introduction 
It is common knowledge that many animals possess and rely heavily upon a highly 
developed sense of smell when locating food, avoiding predators, finding mates, and 
navigating their environments. Humans, who have a rlatively poor sense of smell, often 
employ other animals in the detection of targeted substances by training them to make an 
identifiable response in the presence of volatile compounds that emanate from those 
substances. Dogs have been trained to locate explosives, landmines, illicit drugs and other 
contraband, missing persons, disaster victims, and a wide variety of other targets (Browne et 
al., 2006; Williams & Johnston, 2002). Bees, pigs, mice, rats, and a number of other animals 
have also been successfully trained to identify targeted substances (Bodyak & Slotnick, 1999; 
Poling et al., 2010a; Rains et al., 2008; Talou et al., 1990). 
Several anecdotal reports of dogs spontaneously showing interest in skin cancer on 
their owners have been published. Williams and Pembroke (1989) wrote of a patient whose 
dog persistently sniffed a mole on her leg. The dog’s excessive interest in the mole prompted 
the patient to visit a dermatologist, who identified the mole as a malignant melanoma. Church 
and Williams (2001) reported a man whose dog constantly sniffed at a patch of eczema on his 
leg. After excision of the lesion, it was found to be a basal cell carcinoma. Campbell et al. 
(2013) described a case in which a man’s dog persist ntly licked a lesion behind his right ear, 
which was later confirmed to be malignant melanoma. In each of these cases, the dog was 
apparently able to detect and was attracted to volatile organic compounds (VOCs) emanating 
from the affected area on its owner’s skin. 
VOCs are organic chemicals with high vapor pressure at typical room temperature, 
resulting in evaporation or sublimation of the molecul s into the air surrounding the source. 
VOC profiles reliably associated with asthma, several types of cancer, cholera, cystic fibrosis, 
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diseases, pre-eclampsia, renal disease, and tuberculosis (TB), have been identified (Corradi et 
al., 2010; Dent et al., 2013; Shirasu & Touhara, 2011). Disease-related VOCs may be found 
in the blood, breath, feces, skin, sputum, sweat, urine, and vaginal secretions of affected 
individuals. Research investigating the VOCs associated with various human diseases is 
underway, primarily driven by the goal of developing strumentation for use in clinical 
diagnostics that is capable of reliably identifying specific disease-associated VOC marker 
profiles. Currently, the development of this technology is limited by the prohibitively high 
cost of the necessary laboratory instrumentation and difficulties in standardizing sample 
collection and preparation procedures in clinical settings (Sethi et al., 2013).  
An increasing number of experimental analyses examining animal detection of human 
diseases have appeared in the literature since Pickl et al. (2004) reported the high detection 
accuracy of two dogs trained to detect melanoma. The cumulative number of relevant studies 
published between 2004 and 2016 are displayed in Figure 1. The steepening gradient in the 
data path suggests that interest in this topic has increased over time. This body of literature on 
which Figure 1 is based has been reviewed from various perspectives (Bijland et al., 2013; 
Boedeker et al., 2012; Dent et al., 2013; Desikan, 2013; Freeman & Vatz, 2015; Jezierski et 
al., 2015; Johnen et al., 2013; Lippi & Cervellin, 2012; Luque de Castro & Fernandez-
Peralbo, 2012; Marcus, 2012; McCulloch et al., 2012; Moser & McCulloch, 2010; Oh et al., 
2015; Wells, 2012). Many reviewers and researchers ave remarked that critical components 
of the training and testing procedures in the relevant studies are often unreported or are 
deficient. Therefore, it is difficult to ascertain the potential of animals as detectors of various 
human diseases (e.g., Elliker et al., 2014; Jezierski t al., 2015). The purpose of the present 
article is, first, to suggest required and preferred conditions for training and testing animals 
for operational disease detection and, second, to evaluate the existing research with respect to 
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animal trainers, and medical practitioners who are int rested in olfactory detection of human 
diseases. 
Training Conditions 
Operant discrimination training, in which indication responses (e.g., barks by a dog) 
to samples known to be positive for the disease in question are reinforced (rewarded, as by 
delivery of a preferred food) and responses to samples not known to be positive for the 
disease are not reinforced, is used to teach animals to detect the disease. Once an animal 
reliably emits the indication response only in the pr sence of known-positive samples, 
samples of unknown status are presented and the animal’s response to those samples is 
recorded. Samples that engender an identification response are considered to be disease-
positive according to the animal detector, although additional confirmatory technology is 
often used to ensure the patient who provided the sample actually has the disease. Responses 
to samples of unknown status are not reinforced and, to maintain performance, known-
positive samples have to be included in the sample array. As in training, responses to such 
samples are reinforced. Details of training differ widely across studies, but certain aspects of 
training are of general, and critical, significance. 
Required conditions for training 
The conditions outlined in this section are necessary for training an animal to reliably 
indicate the presence of disease-related VOCs in novel samples. 
Confirmed positive samples. Ideally, the status of every sample used in training ( .e., 
samples that are positive for disease as well as those that are negative for disease) is 
determined with the gold standard or best available diagnostic technology for the targeted 
disease. However, knowing the true status of “positive” samples that will be used to arrange 
reinforcement for correct indications is a required condition. Even occasional reinforcement 
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(positive indications of disease-negative samples). Intermittent reinforcement generates 
patterns of behavior that persist even when reinforcement is no longer forthcoming (Angle et 
al., 2015; Nevin, 1988). Persistent indication of disease-negative samples negatively impacts 
specificity (proportion of disease-negative samples that are accurately classified as such), 
negative predictive value (NPV; the number of correct jections [negative indications] 
divided by the total number of rejections), and positive predictive value (PPV; the number of 
correct positive indications divided by the total number of positive indications). 
Intermittent schedules of reinforcement for correct indication responses have the 
desirable effect of preparing the animal for conditions under which correct indication 
responses cannot be reinforced. Such conditions are inevitable if the animal will be used 
operationally because an animal detector would provide no additional value in an operational 
scenario in which the status of all samples is already known. For this reason, knowing the 
status of all “negative” samples used for training is not a required condition. If a positive 
sample is incorrectly classified as “negative” and the animal’s correct identification response 
is not reinforced, the animal will learn to continue evaluating the remaining samples, as it 
would be required to do in an operational scenario. In early stages of training, while the 
search and indication behaviors are being shaped, a high ratio of reinforcement (i.e., 
continuous reinforcement) is necessary, but the schdule of reinforcement should be 
gradually thinned to match the schedule of reinforcement anticipated under testing and 
operational conditions. Under training conditions i which consequences are provided for 
correct or incorrect identification of negative samples (e.g., Gordon et al., 2008; Walczak et 
al., 2012), it is important that the status of “negative” samples is confirmed with the best 
available diagnostic technology. 
Control (negative) samples that are comparable to positive samples except for disease 
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status with respect to the targeted disease, the animal may learn to rely on these additional 
cues partially or entirely and its true ability to detect disease-positive samples will be 
obscured. For example, because a high percentage of individuals with lung cancer also smoke, 
an animal may dismiss all samples from non-smokers as negative, despite the presence of 
lung cancer in some non-smokers. Matching controls in terms of age, gender, and other 
factors that are likely to influence outcome measure  is standard practice in medical research, 
but consideration of additional factors is necessary when working with animals.  
Control samples collected in a different time period, from a different location, or by a 
different person from the one who collected the positive samples are likely to emit VOCs 
irrelevant to the targeted disease (e.g., volatiles associated with a specific clinic) that may 
function as cues during training. Attempts to prevent cross-contamination between positive 
and control samples can also lead to systematic differences between the samples. For 
example, control samples regularly may be prepared first, by a different person, or in a 
different room. Any systematic discrepancy between sample collection, handling, and 
preparation procedures for positive and control samples can result in cues that control the 
indication response instead of the relevant disease-as ociated volatiles. Under these 
conditions, the animal may perform well under training and testing conditions but poorly 
under independent testing or operational conditions. Because many disease detection research 
projects never reach the stage of independent testing or operational trials, researchers may 
inadvertently obtain and report spurious results. Therefore, it is essential to ensure that there 
are no systematic differences, save for disease status, between positive and negative samples 
used for training and testing. 
A large number of sample sources (patients and healthy controls). Training an animal 
to detect disease-positive samples is, in essence, teaching the animal a concept. If only a few 
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identifying the “positive” samples after a short time, but not necessarily because of what they 
have in common. Pigeons have been trained to indicate the presence of trees, water, people, 
and even a specific person in novel pictures, even though there is no single defining feature 
of any of these concepts (Herrnstein & Loveland, 1964; Herrnstein, Loveland, & Cable, 
1976). In these experiments, key pecking was reinforced when a picture containing the target 
was present and not reinforced when the target was absent. In testing sessions, only novel 
pictures were presented, and the rate of key pecking in the presence of positive (target-
present) and negative (target-absent) pictures was recorded. Herrnstein, Loveland, and Cable 
used approximately 1000 pictures (half negative and half positive) in training and 800 
additional pictures for testing acquisition of each concept. Although these studies did not 
establish the minimum number of training exemplars required for concept formation, if the 
researchers had used only a few pictures for training, it is unlikely that the pigeons would 
have been able to respond accurately to novel pictures during testing. 
When training for disease detection, using multiple tissue or fluid samples from the 
same human is not a solution for training a disease concept for the same reasons that multiple 
copies of the same photo are not useful when training p geons the “tree” concept. In one 
report, dogs trained extensively on one type of 2,4,6-trinitrotoluene (TNT) showed high 
sensitivity (i.e., hit rate) with the type of TNT used in training but failed to indicate other 
types of TNT (Goldblatt et al., 2011). Increasing the variation in training samples led to 
improved generalization. Similar issues were reported in a study on the detection of 
gunpowder (Oxley & Waggoner, 2009). VOC profiles asociated with diseases are much 
more complex than those associated with TNT and gunpowder. Therefore, researchers must 
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A wide variety of positive samples with a single commonality – positive disease 
status – is required; likewise, a wide variety of negative samples with a single commonality – 
negative disease status – is required. The minimum size of the sample set will depend on a 
number of factors including the amount of disease-related VOCs that are available in the 
headspace of a typical sample and the relative availability of unrelated VOCs.  An effective 
approach to training the targeted disease concept when the number of sample sources is 
restricted is as follows: (1) Train with a subset of he available sample sources until the 
animal reaches pre-established performance criteria or until performance is no longer 
improving. (2) Introduce samples from novel positive and control sources and evaluate 
performance with these samples prior to any reinforced indications of the positive samples 
(e.g., on the first presentation of the sample). (3) Include these samples in the training set if 
performance with the novel samples is low, and repeat these steps until performance with 
samples from novel sources is reliably high. With this method, progress toward concept 
formation is regularly evaluated, additional exemplars are systematically added to the training 
set, and the required number of novel sample sources is minimized. 
Preferred conditions for training 
The conditions outlined in this section are not necessarily required for successful 
training of animal detectors of human disease but will typically result in more rapid training 
or higher performance in subsequent testing and operational use. 
Trainer blind to status of all samples. Whenever the trainer has knowledge of the 
disease-status of the samples in the sample set, the likelihood of cuing is very high, even for 
well-intentioned trainers. If the reader is not alre dy convinced of the difficulty of abstaining 
from cuing under non-blind conditions from the story f “Clever Hans,” the research of Lit et 
al. (2011) may provide the required evidence. The res archers conducted tests with drug and 
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time, but certain locations and decoys were marked with a paper marker and others were not. 
The marked locations were statistically significantly more likely to be indicated by the 
dog/handler team than the unmarked locations, confirming that handler beliefs about the 
location of targeted substances had a powerful influe ce on the perceived or actual 
performance of the dogs. Dogs are very receptive to human communicative cues such as hand 
signals, body orientation, and the emotional content of verbal commands (Ruffman & Morris-
Trainor, 2011; Soproni et al., 2002; Virányi et al., 2004). Due to the insidious effects of cuing 
on true scent detection performance, this “preferred condition” is a strong candidate for the 
list of “required conditions.” There are, however, a number of training methods that can 
reduce or eliminate the possibility of cuing. 
One such method involves placing the trainer behind a screen positioned in such a 
way that the trainer can see which samples are being identified as positive but the animal 
cannot see the trainer. When this strategy is used, th  trainer must ensure that no auditory 
cues are accidentally provided (for example, by repositioning a clicker when the animal is 
approaching a positive sample). Another method involves positioning an observer with 
sample status information out of view of the animal and the trainer, who is blind to sample 
status. Each time the animal identifies a sample as positive, the trainer calls out the sample 
position, and the observer immediately replies with the sample status so that the trainer can 
take appropriate action (Elliker et al., 2014; Mahoney et al., 2012). With this type of training, 
the observer must be careful not to provide any auditory cues. Yet another method is to 
construct an apparatus that is capable of reliably detecting a positive identification and 
delivering a reinforcer for identification of samples programmed as positive/reinforcement 
samples (e.g., Mahoney et al., 2014). When “play” is used as the reinforcer, the automated 
apparatus can emit a visual or auditory cue, which s gnals the handler to initiate play, but we 
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Confirmed negative samples. Under typical training conditions, no consequences ar  
scheduled for correct or incorrect identification of negative samples. If, however, “negative” 
samples are known to be negative, consequences can be provided for correct or incorrect 
identification of negative samples. For example, Gordon et al. (2008) and Walczak et al. 
(2012) delivered a mild rebuke when detection dogs incorrectly identified negative samples 
as positive, which presumably served to punish false indications. Zimmerman and Ferster 
(1963) found that arranging punishment in the form f time-outs of 10 s – 1 min from the 
training procedure when an incorrect response occurred in a matching-to-sample task resulted 
in higher accuracy, which suggests that consequences for incorrect responding can increase 
accuracy in a discrimination task. Unfortunately, relevant research in the scent-detection field 
is lacking. 
When it comes to evaluating the animal detector’s performance, working with 
confirmed negative samples allows the trainer to deermine the precise sensitivity (proportion 
of true positives identified as positive) and specificity (proportion of true negatives identified 
as negative) of the detector. When “negative” samples are identified as positive by the animal 
detector, the apparent specificity will decline, but if some of these samples are actually 
positive, the true specificity is higher than the app rent specificity. In other words, the animal 
may appear to be incorrectly identifying negative samples as positive, but some of the 
identifications are actually correct. Therefore, if the status of all samples is not known, the 
trainer does not have an accurate picture of the animal’s true detection performance and does 
not have complete data on which to base decisions. 
Training samples same as operational samples. If a disease-related VOC has been 
identified and can be isolated for training and testing purposes, one of the largest challenges 
in olfactory detection of human diseases – that of sample availability – may be overcome. But 
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operating with human tissues or fluids. Lazarowski and Dorman (2014) found that training 
with potassium chlorate was not sufficient to produce generalization to potassium-chlorate-
based explosive mixtures for most dogs in their study. Bomers et al. (2012) conducted 
training with toxigenic Clostridium difficile strains on culture plates prior to training with 
stool samples, but the influence of the initial training with the isolated VOCs on subsequent 
training with samples obtained directly from patiens was not evaluated. Suckling and Sagar 
(2011) trained honeybees to indicate the presence of hemical compounds that were 
previously found to be associated with TB, but the be s were not subsequently tested with 
samples obtained from humans. When training animals for clinical use, it is generally 
advisable to train under the conditions in which the animal detector will be tested, which 
should in turn be the same conditions under which the animal will operate. 
Positive sample prevalence similar to prevalence of disease in operational setting. 
Training of animals for any purpose usually proceeds stepwise with simple, fundamental 
responses trained first, followed by the establishment of more complex responses in more 
difficult training conditions. Animals trained to detect human diseases should eventually be 
trained to identify the positive samples in a sample set where the prevalence of positive 
samples is similar to the prevalence of the disease in the targeted operational scenario. For 
example, dogs under training for eventual screening of skin samples for skin cancer from a 
dermatological clinic where six percent of the samples are tested positive for skin cancer 
should eventually be trained under conditions where 94% of the skin samples are negative. 
Wolfe et al. (2005) found that the percentage of missed targets increased substantially when 
the prevalence of targets was reduced in a visual search task with humans (50% prevalence 
produced 7% miss errors while 1% prevalence produced 30% miss errors). Target prevalence 
is a critical factor that is likely to impact the probability of hits, false indications, and other 
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samples in training should match that of testing, which should match the prevalence 
anticipated in operations as closely as possible. 
Intermittent reinforcement. If identification responses are reinforced every time a 
positive sample is correctly identified, the response will deteriorate quickly under testing and 
operational conditions in which the status of some proportion of samples is unknown and, 
therefore, some correct identifications cannot be reinforced. Behavior that is reinforced 
intermittently is more persistent when it is no longer reinforced (i.e., it is more resistant to 
extinction) than behavior that is reinforced each time it occurs (Nevin, 1988; 2012). But, in 
order to avoid degrading an animal’s performance, int rmittent reinforcement must be 
introduced gradually. If the trainer goes from reinforcing every correct response to 
reinforcing every 20th correct response, the animal will probably not make it to the 20th 
response before shifting to other behavior that has a higher likelihood of being reinforced. As 
with positive sample prevalence, the rate of reinforcement should be adjusted gradually to 
match the rate that is expected to be encountered in testing and operational scenarios. For 
example, if approximately 25% of the positive samples in an operational scenario will have 
known status, then the animal should be gradually shifted to a schedule of reinforcement 
under which only 25% of correct identifications, on average, are reinforced. 
Testing Conditions 
Required conditions for testing 
Testing is usually conducted to determine the sensitivity and specificity of the animal 
as a detector of the targeted disease after a period of training. Other variables may also be 
investigated when an animal detector is tested, such as evaluation speed, stamina, and 
resistance to extinction. For a test to provide a convincing demonstration of an animal’s 
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Sample sources differ from sources used in training. Samples collected for testing 
purposes must not come from the same individuals as the amples used for training purposes. 
If the animal detector is given the opportunity to respond to samples that were taken from the 
same individuals who provided training samples, it cannot be determined with any degree of 
certainty that the animal’s identification responses are being controlled by disease-related 
VOCs rather than other volatiles unique to the individual who provided the sample. Using 
samples that have already been used in training would pose an even larger threat to the 
validity of the test, as it would be easier still for the animal to identify samples that were 
correctly identified during training without regard for their disease-status. 
Trainer blind to status of all samples and presence of positive samples. Results from 
testing conducted under non-blind conditions cannot be considered as valid. Not only must 
the trainer be unaware of the status of individual samples, he or she must also be unaware of 
the number of positive samples that are present in any set of samples under evaluation (e.g., 
in each run, with “run” meaning a set of samples simultaneously presented to an animal for 
evaluation). For example, if an animal is tested with sequential presentations of eight-sample 
runs comprising one positive and seven control samples, the animal and trainer are afforded 
significantly more information than would be available under operational conditions in which 
any number of samples could be positive in any sample set. This problem is further 
compounded with “forced choice” procedures in which the animal must choose one and only 
one sample from each run. With forced choice procedures, the trainer often makes a judgment 
call regarding which sample was selected, and the animal is likely to be influenced by some 
form of cuing (e.g., the trainer encourages the dog to indicate one of the samples).  
Additionally, standard measures of diagnostic accura y obtained from such 
procedures are not valid, particularly specificity and negative predictive value (NPV). For 
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(in each set of seven samples, one is positive, and the og must indicate only one sample each 
run), even if it misses the positive sample each time, it will only be able to indicate one of the 
six negative samples in each run, therefore establihing a floor of one in six samples 
incorrectly identified as positive, which translates o a minimum specificity and NPV of 83%. 
If the dog had instead correctly identified the positive sample in each run, specificity and 
NPV would be 100% by default. These values are not representative of the animal’s 
performance and do not provide any indication of how it might perform in circumstances 
where an unknown number of positive and negative samples are present. For accurate 
calculation of diagnostic accuracy, it is necessary to have a variable number of targets in runs 
and a protocol that ensures that the animal can make a positive indication to any sample. 
Accurate knowledge of sample status. In order to accurately determine the sensitivity 
and specificity of the animal detector, the disease-status of the samples must be known with a 
high degree of certainty. This typically involves determining the status of the samples using 
the “gold standard” diagnostic test, which is the best available test for the disease. 
Particularly when conducting proof-of-concept testing, for the test results to be convincing to 
interested parties, the reference technology should be the best available under the 
circumstances. Follow-up testing of individuals who were found to be disease-negative 
according to gold standard technology but positive according to animal detectors can provide 
information regarding the ability of animals to identify diseases in early stages. 
Control (negative) samples that are comparable to positive samples except for disease 
status. For the same reasons provided under Training Conditi s, positive and negative 
samples must not differ in any systematic way. If such differences exist, any test of the 
animal’s disease detection performance will be inval d because the animal may be responding 
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Sufficiently large number of sample sources. The number of sample sources used in 
the test should be based on an appropriate sample-size calculation conducted prior to the test. 
A variety of tools have been developed for this purpose, including formulas (Jones et al., 
2003), nomograms (Carley et al., 2005), tables (Flahault et al., 2005), and software designed 
for conducting power analyses for diagnostic accuracy tests. An inadequate number of 
samples will result in extremely wide confidence intervals around the obtained accuracy 
measures, rendering the results of the test meaningless (Hajian-Tilaki, 2011). 
Two examples calculated using the R (R Core Team, 2015) power.diagnostic.test 
function in the MKmisc package (version 0.991) illustrate the range of sample sizes that are 
necessary to establish estimates of sensitivity. In the first example, the expected sensitivity of 
the detector is 0.9, and the researcher wishes to etablish 95% confidence intervals for 
sensitivity with a lower limit of no less than 0.75 Samples from 74 disease-positive 
individuals would be required. In this example, if the animal were to be tested with a disease 
prevalence of 0.1, samples from 666 disease-negative individuals would also be required. In 
another example, the expected sensitivity of the det ctor is 0.8, and the researcher wishes to 
establish 95% confidence intervals for sensitivity with a lower limit of no less than 0.7. In 
this case, samples from 215 disease-positive individuals would be required. If testing with a 
disease prevalence of 0.05, samples from 4,085 disease-negative individuals would also be 
required. Both of these examples are representative of typical conditions and highlight the 
importance of conducting appropriate tests when determining the number of samples that 
must be included in evaluations of animal detectors of human diseases. 
Preferred conditions for testing 
The conditions described in this section may not be necessary for a test to be 
considered valid or for a test to produce useful results but are generally desirable for the 
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Mechanical or other objective determination of identification response. With 
explosives detection and many other scent detection tasks, the animal/trainer pair can be 
considered a single unit, the animal reacting to the targeted volatiles, and the trainer reacting 
to the animal’s reaction. Nonetheless, the requirement that a trainer identify a response as 
indicative of the presence of the targeted substance can lead to subjective interpretation of the 
animal’s behavior. While some level of subjectivity can be tolerated in the highly variable 
conditions encountered in explosives detection and other related work (especially when it 
involves erring on the side of caution), in a contrlled laboratory setting where disease 
detection work will take place, removing human subjectivity from the equation is advisable 
for several reasons: the apparent performance of the animal may fluctuate if the trainer is 
distracted or if one trainer is substituted for another; independent observers may not be able 
to obtain consistent data from the same test, and; the trainer must make a judgment call on 
“borderline” identification responses. As with training, an automated testing apparatus may 
be the best solution, but when construction of such a device is not feasible, an objective 
definition of an identification response that enables independent observers to obtain high 
levels of agreement should be developed and used during testing. 
Positive sample prevalence similar to prevalence of disease in operational setting. 
When detection animals are being evaluated for a specific operational application, the 
prevalence of positive samples in the test should accur tely reflect the prevalence in the 
targeted operational population. If, for example, the animal is tested with a positive sample 
prevalence of 10%, but the prevalence of the disease in the targeted population is 1%, the 
information gained from the test will not be sufficient to estimate the performance of the 
animal detector in the operational setting. Detection performance can and should be expected 
to vary depending upon the prevalence of positive samples in the sample set (Evans et al., 
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Other testing conditions similar to operational conditions. Other testing conditions 
such as sample quantity and quality (including method of collection, age, and storage 
conditions), session duration, testing environment, a d schedule of reinforcement should be 
similar to those anticipated in operational conditions. Reinforcement samples may be 
interspersed among the testing samples if such an arr gement would be operationally 
feasible, but the prevalence and quality of these samples should be similar to samples 
expected to be available under operational conditions. Any discrepancy between training and 
anticipated operational conditions, such as the use of dried rather than fresh blood, may cast 
doubt on the suitability of the test for evaluating the animal detector’s potential for 
operational use. 
Independent evaluation. It is preferable for animal detectors in the testing phase to be 
independently evaluated by a third party to verify the accuracy of the animal detectors and 
confirm that preliminary results were not spuriously obtained. Well-trained and well-
intentioned researchers can unintentionally build cues into the training process and obtain 
results that cannot be replicated by others. Independent evaluation of detection animals can 
take a variety of forms, the simplest of which involves testing of samples that have been 
provided by a third party without sample classification. The results obtained from the animal 
detector are submitted to the third party who then reveals the sample classification and the 
performance of the detector. Other arrangements, such as independent replication of findings 
across multiple laboratories, can build confidence i  the findings and strengthen the case for 
operational deployment. 
Operational Conditions 
Required conditions for operations 
The conditions that are required for successful operations with animal detectors 
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take place. Despite this, several overarching requiments can be identified and will be 
described briefly below. 
Ongoing training. Animals are constantly learning and, unless appropriate training is 
arranged frequently, detection performance will inev tably decline. Ongoing training can only 
be foregone when identification of positive samples is intrinsically reinforcing, as it appears 
to be for some dogs that spontaneously show interest in their owners’ skin cancer or with 
nematodes employed as described by Hirotsu et al. (2015), for example. Three possibilities 
for conducting ongoing training will be described here, although other methods may exist. 
 The first method involves interspersing known samples (training samples) among 
samples with unknown status (evaluation samples). Correct identifications of positive 
training samples are reinforced and correct identifications of positive evaluation samples are 
not reinforced, essentially maintaining the identification of positive samples under an 
intermittent schedule of reinforcement. The second method involves alternating between 
training sample runs and evaluation sample runs. During the runs with training samples, 
correct positive indications are reinforced, whereas no indications are reinforced during runs 
with evaluation samples. The third method involves training with samples with known status 
on some days or sessions and evaluating samples with unknown status on others. Although 
they have not been systematically compared, the three methods are likely to produce different 
performance. Therefore, as specified under preferred conditions for testing, the testing 
conditions should match the operational arrangement.  
Regardless of the method of known-sample interspersal, the operational settings 
should involve a high rate of reinforcement whenever feasible. Sargisson and McLean (2010) 
found that higher rates of reinforcement (35-75%) produced higher sensitivity in remote 














ANIMAL OLFACTORY DETECTION OF HUMAN DISEASES 20 
Training conditions cannot be discriminable from operational conditions. 
If an animal can discriminate between training and evaluation conditions or between training 
and evaluation samples, performance with the evaluation samples will suffer because correct 
identification of training samples is differentially reinforced (i.e., indication of positive 
training samples is reliably reinforced while indication of positive evaluation samples is 
never reinforced). If, for example, the training samples are stored in the freezer and the 
evaluation samples are not, the animal might be ablto discriminate between samples that 
were frozen, which are reinforced if correctly identified, and those that were not frozen, and 
to which responses are never reinforced. Therefore, the animal would not respond to samples 
that were not stored in the freezer. Likewise, if training sessions are conducted in one setting 
and operational evaluation is conducted in another,  animal’s performance in the 
operational setting will decline. 
Regular evaluation of performance with another diagnostic tool. Regular comparison 
of animal performance with another diagnostic tool enables the trainer to identify changes in 
performance and take corrective action if necessary. Performance during training or with 
training samples is not sufficient for performance evaluation because of the potential for 
discrimination between training and evaluation samples as described earlier. An animal’s 
performance in training can be very good while its performance during operational evaluation 
is very poor, in which case the trainer must identify and eliminate the discriminable 
difference between training and operational conditions. As this type of evaluation is likely to 
impact the cost-effectiveness of animal detection solutions, the frequency of these 
comparisons can be minimized by adopting and enforci g rigorous standard operating 
procedures, particularly those associated with sample collection and preparation. 
Standard operating procedures. Reliably accurate performance is key to the utility 
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solution to behavioral variability is standardization of operating procedures. All aspects of 
ongoing training, housing, feeding, session timing, sample collection, sample preparation, 
and all other laboratory practice must be clearly defined. After all procedures have been 
described in detail, arrangements for quality assurance must be put in place to ensure that 
procedures are being followed as described. Althoug standard operating procedures cannot 
eliminate all behavioral variability, well-written procedures with strict adherence can 
eliminate much of the variability that is within the operator’s control. Standard operating 
procedures should also be developed and followed for training and testing. 
Preferred conditions for operations 
Consistent sample quality and quantity. A stable flow of both training and evaluation 
samples makes regular training and operations possible. If training or operations are 
frequently interrupted, particularly for long periods, retraining and retesting may be necessary 
before operations can resume. Animal detectors may be able to attain a high level of 
performance when the quality of samples in an operation l scenario varies widely, but if there 
is a major shift in sample quality, performance is likely to be adversely affected. If, for 
example, operations are shifted from a clinical setting where samples come from 
symptomatic individuals to a non-clinical setting, where the samples come from a variety of 
symptomatic and non-symptomatic individuals, performance should be expected to change 
because of the shift in sample characteristics and disease prevalence. When shifting to a new 
operational setting, training and testing should be conducted to ensure that the animal 
detectors are capable of performing as required in the new setting. 
Periodic evaluation of performance relative to gold standard. Frequent evaluation of 
the animal detector’s performance relative to the gold standard can be prohibitively time-
consuming and expensive depending upon the current gold standard for the relevant disease, 













ANIMAL OLFACTORY DETECTION OF HUMAN DISEASES 22 
standard diagnostic technology can provide the most accurate estimates of the animal 
detector’s sensitivity and specificity (if the sample-size is sufficiently large). 
These required and preferred conditions for each stage of the pathway from initial 
training to operational deployment are undoubtedly incomplete, and there are bound to be 
exceptions that we have not mentioned. Nonetheless, we hope and expect that consideration 
of these conditions will be of benefit to people who are interested or involved in olfactory 
detection of human diseases. With these required and preferred conditions serving as points 
for comparison, a review of relevant experimental research was conducted.  
 
Method 
The PubMed and Web of Science databases were searched on 25 August 2016 
using combinations of the terms: “animal,” “cancer,” “canine,” “chemota*”, “dog,” “detect*,” 
“disease,” “odour”, “odor,” “olfact*,” “scent,” and “smell.” Articles that described original 
research involving animal olfactory detection of human disease using samples collected from 
human participants were selected for inclusion. In evaluating the performance of the animal 
detectors, gold standard technology must have been us d to confirm the status of positive 
samples used for testing. Articles describing animal olf ctory detection of psychiatric 
conditions were excluded from the present review because no gold standard diagnostic 
technology exists for such conditions. Articles describing the use of chemotactic assays with 
animals for the detection of human diseases were included. Studies examining detection of 
samples obtained during hypoglycemic episodes were included, although hypoglycemia is 
not classified as a disease. Additional articles meeting the inclusion criteria that were 
discovered in a subsequent forward and backward ancestral search of the selected articles 
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Three tables were prepared for organization and analysis of the findings. In Table 1, 
basic information about the studies was compiled. In Table 2, key features of training as 
outlined in the required and preferred conditions for training provided in the Introduction 
were organized. Categories in Table 3 were chosen according to the required conditions for 
testing provided in the Introduction. A final column in Table 3 was used to classify the 
testing conditions in each study as feasible for operations and, therefore, valid evaluations of 
the capabilities of disease detection animals, or not, based on the other items in the table. One 
coder compiled the information reported in Tables 1 through 3. A second coder 
independently evaluated 7 of the 28 studies (25%) and checked the information obtained 
from the remaining 21 studies for accuracy. Using the independently coded studies, a 
measure of inter-coder agreement was obtained by dividing the number of fields in the tables 
in which agreement with the original coder was obtained by the total number of fields. This 
resulted in an agreement percentage of 73%. Coders discussed inconsistencies in data 
extracted from each of the studies and updated the tabl s after reaching consensus. 
 
Results 
A brief summary of key information from each of the studies is provided in Table 1, 
including the disease targeted for detection, the typ of sample, the animal detector, and the 
sensitivity and specificity obtained in the study. Cancer detection has clearly received the 
most attention, with 20 of the 27 studies targeting o e or more cancers. Of the remaining 
seven studies, four have targeted TB, two hypoglycemia, one bacteriuria, and one 
Clostridium difficile. Urine samples have been used in 11 studies, breath samples in 6, 
sputum in 4, tissue in 3, stool in 2, blood in 2, and live patients in 1. The only exceptions to 
canine detectors in the reviewed studies were pouched rats in four studies and nematodes in 
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chance performance, with considerable variation even among studies examining the same 
disease, sample, and detector. A fixed number of positive samples were present during test 
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Table 1. Study summary 
Year 1st Author Disease Sample Detector Mean Sensitivity Mean Specificity 
2004 Pickel Cancer: melanoma Tissue Dog (Canis familiaris) 
(2) 
Samples in run: 100% 
Samples planted on healthy 
volunteers: 100% 
Actual patients: 80% 
FCa 
2004 Willis Cancer: bladder Urine Dog (6) Wet urine: 50% 
Dry urine: 22% 
Overall: 41% 
FCa 
2006 McCulloch Cancer: lung, breast Breath Dog (5) Lung: 99% 
Breast: 88% 
FCa (lung: 99%; breast: 
98% reported) 
2008 Gordon Cancer: breast, 
prostate 
Urine Dog (10; bc: 6, pc: 4) Breast: 22% 
Prostate: 18% 
FCa 
2008 Horvath Cancer: ovarian Tissue Dog (1) 100% 98% (fixed number of 
positives in each run) 
2009 Weetjens Tuberculosis Sputum Pouched rat (Cricetomys 
ansorgei) (20 trained, 2 
testedb) 
73% 93% 
2010 Horvath Cancer: ovarian Tissue, blood 
plasma 
Dog (2) Tissue: 100% 
Blood: 100%  
FCa (tissue: 95%; blood: 
98% reported) 
2010 Willis Cancer: bladder Urine Dog (4) 64% 3 contr l groups - healthy: 
89%, disease: 83%, 
urological disease: 61% 
(fixed number of positives 
in each run) 
2011 Cornu Cancer: prostate Urine Dog (1) 91% FCa (91% reported) 
2011 Mgode Tuberculosis Sputum Pouched rat (10) Mean: UC 
2/10 cutoff: 80% 
Mean: UC 
2/10 cutoff: 72% 
2011 Sonoda Cancer: colorectal Breath, stool Dog (1) Breath: 91% 
Stool: 97% 
FCa (breath: 99%; stool: 
99% reported) 
2012 Bomers Clostridium difficile Stool, patient Dog (1) Stool: 100% 
Patient: 83% 
Stool:100% 
Patient: 98% (fixed number 
of positives in each run) 
2012 Buszewski Cancer: lung Breath Dog (UC) 82% FCa (82% reported) 
2012 Ehmann Cancer: lung Breath Dog (4) 71% FCa (93% reported) 
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2/10 cutoffc: 81% 
3/10 cutoffc: 76% 
2/10 cutoffc: 76% 
3/10 cutoffc: 82% 
2012 Walczak Cancer: breast, lung, 
melanoma 
Breath Dog (6 trained, 3 tested) 37% (all cancer types tested 
together) 
FCa 
2013 Dehlinger Hypoglycemia Skin swab Dog (3) Mean: 56% Mean 53% 
2013 Horvath Cancer: ovarian Blood plasma Dog (2) Series 1 (during 
chemotherapy): 97% 
Series 2 (3 month follow 
up): 70% 
Series 2 (6 month follow 
up): 80% 
Series 1: 99%; series 2 (3 
month follow up): 95%; 
series 3 (6 month follow 
up): 92% reported (fixed 
number of positives in each 
run) 
2014 Amundsen Cancer: lung Breath, urine 
(training with 
tissue) 
Dog (4) Breath test 1: 65% 
Breath test 2: 56% 
Urine test 1: 74% 
Urine test 2: 64% 
Breath test 1: 8% 
Breath test 2: 33% 
Urine test 1: 25% 
Urine test 2: 29% 
2014 Elliker Cancer: prostate Urine Dog (10 trained, 2 tested) 19% FCa (73% reported) 
2014 Rudnicka Cancer: lung Breath Dog (2) 86% FCa (72% reported) 
2015 Hardin Hypoglycemia Perspiration & 
breath (combined) 
Dog (6) 78% FCa (96% reported) 
2015 Hirotsu Cancer: 
oesophageal, gastric, 
colorectal, breast, 
pancreatic, bile duct, 
prostate 
Urine (preliminary 
testing with cell 
cultures, tissue, 




2015 Reither Tuberculosis Sputum Pouched rat (7) Mean: 41% 
1/7 cutoff: 72% 
2/7 cutoff: 57% 
Mean: 87% 
1/7 cutoff: 59% 




Torri, et al. 




Stork, et al. 
Cancer: prostate Urine Dog (2) Pre-operative: 100% UC 
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96.3% (fixed number of 
positives in each run) 
Note. FC = forced choice; UC = unclear. 
a With forced choice procedures, specificity calculations are invalid. 
b Comparison to culture (gold standard) in Experiment 1 only. 
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Table 2 summarizes key aspects of the training conditi s in each of the studies. 
In six studies and in one condition of a seventh study, all training samples were evaluated 
with gold standard technology. In 12 studies and in one condition in a thirteenth study, at 
least some of the control samples were obtained from healthy but untested individuals. In 
three studies, all samples were evaluated with microscopy, which is highly specific but 
not sensitive for diagnosis of TB. For four studies, no information regarding testing of 
training samples was provided. Training procedures w re not reported by Hirotsu et al. 
(2015) because training was not required for their approach to cancer detection involving 
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Table 2. Training conditions 
Year 1st Author Known sample status 
(positive and negative 
tested with gold 
standard technology) 
Controls comparable to 
positive samples 








Prevalence of positives 
in sample set 




2004 Pickel Y N (non-tissue controls) tm: UC 
tsp: 1 
N/A N tm: N (retrieval 
training) 
tsp: Y 
tm: UC (1) 
tsp: UC (1) 
UC 
2004 Willis N (untested controls) Y 27 54 N Y 7 (1) 14% 
2006 McCulloch N (untested controls) N (only healthy controls) lc: 27  
bc: 25 
66 Y Y 5 (1) 20% 




Y Y 7 (1) 14% 
2008 Horvath Y N (pos. and cont. in 
separate rooms) 
31 UC N Y 10 (2) 20% 
2009 Weetjensa N (microscopy not gold 
standard) 
Y UC UC Y Y 10 (UC) 5-20% 
2010 Horvath ts: Y 
bls: N (untested controls) 
ts: Y 
bls: N (younger controls, 
some males) 
UC UC N Y 6 (1) 17% 
2010 Willis N (untested controls) Y UC UC N Y 7 (0-1+) UC 
2011 Cornu Y Y 26 16 N N (different run 
size) 
2 (1) 50% 
2011 Mgodeb N (microscopy not gold 
standard) 
Y UC UC Y Y 10 (UC) 5-20% 
2011 Sonoda UC UC UC UC N Y 5 (1) 20% 
2012 Bomers Y Y UC UC N N (different 
sample types) 
UC UC 
2012 Buszewski N (untested controls) N (only healthy controls) UC UC UC Y 5 (1) 20% 
2012 Ehmann N (untested controls) Y 35 60 UC Y UC UC 
2012 Mahoneya N (microscopy not gold 
standard) 
Y UC UC Y Y 10 (UC) 5-20% 
2012 Walczak N (untested controls) N (only healthy controls) bc: 57 
m: 45 
lc: 118 
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2013 Dehlinger UC UC UC UC UC UC UC UC 
2013 Horvathc UC UC UC UC N N (different run 
size) 
4-10 (0-3) UC 
2014 Amundsen N (untested controls) UC ts: 1 
bs: UC 
us: UC 
20 UC UC 6 (0-6) 50% 
2014 Elliker N (untested controls) Y 50 67 Y Y 4 (1) 25% 
2014 Rudnickad N (untested controls) N (only healthy controls) bc:57 
m: 45 
lc: 118 
305 Y Y 5 (1) 20% 
2015 Hardin Y Y UCe UC Y (no handler 
present) 
Y 7 (1) 14% 
2015 Horitsu N/A N/A N/A N/A N/A N/A N/A N/A 
2015 Reitherf Y (196 known samples 
prior to test) 
Y UC UC Y Y 10 (UC) 5-20% 
2015 Taverna, 
Tidu, Grizzi, 
Torri, et al. 
N (untested controls) Y (but 23% of control 
samples from females) 
200 230 Y Y 6 (0-6) UC 
2015 Taverna, 
Tidu, Grizzi, 
Stork, et al. 
N (untested controls) Y (but 23% of control 
samples from females) 
200 230 Y Y 6 (0-6) UC 
2015 Urbanova Y Y UC UC UC Y 3 (1) 33% 
2016 Maurer Y Y UC UC N Y 5 (1) 20% 
Note. bc = breast cancer; bs = breath sample; bls = blood sample; lc = lung cancer; m = melanoma; N/A = not applicable; pc = prostate cancer; ss = stool sample; 
tm = tissue mixture; ts = tissue sample; tsp = tissue sample planted on person; UC = unclear; us = urine sample. 
a Training information obtained from Poling et al. (2011). 
b Training information obtained from Weetjens et al. (2009). 
c Training information obtained from Horvath et al. (2008) and Horvath et al. (2010). 
d Training information obtained from Walczak et al. (2012). 
e Positive and negative samples obtained from same individuals. 
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In 16 studies and in one condition of a seventeenth, the set of control samples 
appears to have been comparable to the positive samples with respect to sample quality 
and patient characteristics. But, the possibility remains that unreported differences 
between positive and control sample sets may have existed in any of these experiments. 
For five studies, insufficient detail was provided to make the determination. Pickel et al. 
(2004) used medical supplies, such as bandages and tape, but no tissue samples as 
controls when training dogs to detect tissue samples with melanoma. Horvath et al. 
(2008) specified that positive and control samples w re prepared in separate rooms, 
which may have introduced additional cues associated with positive and negative samples. 
In the remaining 6 studies and in one condition in a seventh study, all of the control 
samples came from individuals who were asymptomatic or differed from the target 
population in other ways. 
For studies and conditions in which relevant information was provided, the 
number of sample sources ranged from 1 to 200 (Median = 45) for positive sample 
sources and from 16 to 305 (Median = 94) for control sample sources. The authors did 
not specify the number of individuals from which training samples were collected in at 
least one condition in 17 of the reviewed studies. 
The handler was blind to the status of individual samples (at least during the final 
stage of training) in 12 of the studies. In 10 studies, the handler was not blind to sample 
status during training. In five studies this information was unclear or unspecified. 
In 21 of the 27 studies, the training conditions corresponded with the testing 
conditions, as reported. Pickel et al. (2004) trained using search and retrieval trials with 
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samples, planting samples on a healthy volunteer, and allowing the dogs to search 
patients with melanoma. Bomers et al. (2012) tested, but did not train, with live patients. 
In two studies, the number of samples in each run differed between training and testing 
(Cornu et al., 2011; Horvath et al., 2013). Two reports provided insufficient information 
regarding the similarity of training and testing conditions (Amundsen et al., 2014; 
Dehlinger et al., 2013). 
Sample runs contained a fixed number of samples in 22 of the studies. The size of 
these runs ranged from 2 to 10 (Median = 6). Sample runs in 13 of these 22 studies 
contained one positive sample, and in another study contained two positive samples 
(Horvath et al., 2008). In 4 of these 22 studies, each run contained a variable number of 
positive samples and, in the remaining 4 studies, the number of positive samples in each 
run was not specified. The authors did not specify the number of samples in training runs 
for four of the studies. Pickel et al. (2004) reported that a single positive sample was 
present in each run but did not specify the run size, while the other three studies did not 
report the run size or the number of positive samples in each run. Horvath et al. (2013) 
employed training runs of varying sizes (4-10) with a varying number of positive samples 
(0-3). Authors reported or we were able to calculate the prevalence of positive samples in 
the training set for 19 of the 27 studies. In these studies, prevalence ranged from 5% to 
50% (Median = 20%). 
Table 3 summarizes critical aspects of the testing conditions reported in each of 
the studies as described under the required conditis for testing provided in the 
Introduction. For the 20 studies in which sufficient information was provided to make the 
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individuals who provided samples for testing of theanimal detectors, with the exception 
of the planted tissue samples used in one study (Pickel et al., 2004). In the remaining 
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Table 3. Testing conditions 


















Number of sample sources Prevalence of positives 









































pa: Y  
ts: N (FCb) 
tsp: N (planting tissue 
on volunteers) 
pa: UC (bandages 
over suspected and 
non-suspected areas) 
2004 Willis Y N (untested 
controls) 
Y 9 54 7 (1) 14% status: Y 
presence: N 
N: FCb 







17 5 (1) 20% status: Y 
presence: N 
N: FCb 
2008 Gordon Y N (untested 
controls) 






14% status: Y 
presence: N  
N: FCb 
2008 Horvath UC if from 
other 
individuals 




20 UC 10 (2) 20% status: Y 
presence: N 
N: fixed number of 
positives in each run, 
ts 
2009 Weetjens Y Y Y UC UC 10 (UC) 8% status: Y 
presence: Y 
Y (if variable number 
of positives in runs) 
2010 Horvath UC if from 
other 
individuals 









UC UC 6 (1) 17% status: Y 
presence: N 
N: FCb 
2010 Willis Y N (untested 
controls) 
Y 30 180 7 (1) 14% status: Y 
presence: N  
N: fixed number of 
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2011 Cornu Y Y Y 33 33 6 (1) 17% status: Y 
presence: N 
N: FCb 
2011 Mgode Y Y Y 56 228 10 (UC)c UC status: Y 
presence: Y 
 
Y (if variable number 
of positives in runs) 
2011 Sonoda Y Y 
 




5 (1) 20% status: Y 
presence: N 
N: FCb, ss collected 
during colonoscopy 











ss: 1 (0-1)  







ss: Y  
pa: N (fixed number 
of positives in each 
run) 





UC UC 5 (1) 20% status: Y 
presence: N 
N: FCb 
2012 Ehmann Y N (untested 
controls) 
Y 25 100 5 (1) 20% status: Y 
presence: N 
N: FCb 
2012 Mahoney Y Y Y 81 409 10 (UC) 18% status: Y 
presence: Y 
Y (if variable number 
of positives in runs) 








29 UC 5 (1) 20% status: Y 
presence: N 
N: FCb 
2013 Dehlinger Y Y Y 3d 3d 1 (0-1) 50% status: Y 
presence: Y 
Y (but high 
prevalence) 





Series 1: 42 








Series 1: 210 











29% status: Y 
presence: N 
N: fixed number of 
positives in each run 
2014 Amundsen Y Y Y UC UC 6 (0-6) 50% status: Y 
presence: Y 
Y (but high 
prevalence) 
2014 Elliker Y N (untested 
controls) 
Y Test 1: 15 
Test 2 & 3: 
16 
Test 1: 45 
Test 2 & 3: 
48 
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2014 Rudnicka Y N (untested 
controls) 
Y 108 145 5 (1) 20% status: Y 
presence: N 
N: FCb 
2015 Hardin UC Y Y UCd UCd 7 (1) 14% N/A (handler 
not present) 
N: FCb 




218 1 (0-1) N/Ae status: Yf 
presence: Y 
Y 
2015 Reither Y Y Y 109 360 10 (UC) UC status: Y 
presence: Y 
Y (if variable number 




Torri, et al. 
Y N (untested 
controls) 











Stork, et al. 
Y UC (no 
control 
information) 
UC 114 0 UC UC UC UC 
2015 Urbanova UC Y Y 45 25 3 (1) 33% status: Y 
presence: N 
N: FCb 
2016 Maurer Y Y Y 231 (191 E





456 5(0-1)g 20% status: Y 
presence: UCg 
N: fixed number of 
positives in each rung 
Note. bc = breast cancer; bs = breath sample; FC = forced choice; lc = lung cancer; pa = patients, pc = prostate cancer; ss = stool sample; ts = tissue samples; tsp 
= tissue sample planted on person; UC = unclear. 
a 10-11 stimuli reported on target-present test trials but number of stimuli present on target-absent trials unclear (only results from target-present trials were 
reported). 
b With FC procedures, the detection task involves locating a fixed number of positive samples in a run of fixed size. Such conditions cannot be arranged in an 
operational scenario.  
c From Weetjens et al. (2009). 
d Positive and negative samples collected from the same sources. 
e Individual worms did not evaluate all samples. 
f Automated chemotaxis assay (Bargmann et al., 1993; Yoshida et al., 2012). 
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Researchers used positive and negative samples testd with gold standard 
diagnostic technology in 12 studies, and in one condition in two other studies. In 12 
studies and one condition in two more studies, positive samples were tested with gold 
standard technology but some proportion of control samples were not tested. These 
control samples were typically obtained from healthy volunteers. Pickel et al. (2004) used 
non-biological controls such as gauze and latex gloves. Taverna et al. (2015b) provided 
no information indicating that control samples were us d. 
Based on the information provided, positive and control samples used for testing 
appear to have been comparable, with the following exceptions. Pickel et al. (2004) used 
non-tissue controls in two conditions. In four studies, only healthy controls were used, 
and in another study the controls were significantly younger than individuals providing 
positive samples. Taverna et al. (2015b) provided no information about control samples. 
The number of positive sample sources used for testing ranged from 1 to 362 
(Median = 29) in the 22 studies reporting this information. The number of negative 
sample sources ranged from 0 to 540 (Median = 116) in the 18 studies with relevant 
information. Studies involving detection of samples obtained during hypoglycemic 
episodes were not included in this summary because control and positive sample sources 
are the same and a large number of sources is not necessary for an adequate test of a 
detector’s performance with this application. Authors did not specify the number of 
sample sources or this information was unclear in five and seven studies for positive and 
negative samples, respectively. 
Runs consisted of a fixed number of samples in 26 studies and in one condition of 
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was presented to the animal for evaluation (Bomers et al., 2012; Dehlinger et al., 2013; 
Hirotsu et al., 2015). In the remaining studies andconditions, run size ranged from 3 to 
10 (Median = 6). In at least one condition of 16 studies, each run included one positive 
sample. Maurer et al. (Maurer et al., 2016) included one positive sample in each run but 
also arranged an unspecified number of runs with no positive samples. Horvath et al. 
(2008) and Horvath et al. (2013) included two positive samples in each run. In at least 
one condition in nine studies, runs included a variable number of positive samples. 
Taverna et al. (2015b) included no information on the composition or size of runs. In the 
24 studies with sufficient information to calculate positive sample prevalence, prevalence 
ranged from 8% to 50% (Median = 20%). These prevalence values differ from prevalnce 
as calculated from the number of positive and control sample sources, 10% to 64% 
(Median = 20%). In 10 of the 21 study conditions with sufficient information for 
comparison, sample prevalence and source prevalence did not match, indicating that 
control or positive samples from the same source wer  presented to the detector a 
disproportionate number of times. 
Individuals working with the detector did not know the status of individual 
samples in all 26 of the studies in which the relevant information was reported. In 15 
studies and at least one condition in two additional studies, handlers were aware of the 
number of positive samples in each run. Maurer et al. (2016) did not specify if handlers 
knew which runs contained no positive samples. 
Based on the criteria outlined under the required conditions for testing provided in 
the Introduction, we consider the methods used in the 16 studies and two conditions in 
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positive samples in each run unsuitable for evaluating the operational viability of disease 
detection animals. Maurer et al. (2016) included runs with no positive samples during 
testing, but this arrangement does not allow for multiple positive samples in a single run 
and is not operationally feasible. Pickel et al. (2004) planted tissue samples on volunteers 
in one condition, which does not appear to be an operationally feasible method. In 
another condition, they put bandages on suspected and non-suspected areas, but it is not 
clear if this is an operationally feasible approach to melanoma detection. Horvath (2008) 
used tissue samples for detection of ovarian cancer and Sonoda (2011) used stool samples 
that were obtained during colonoscopy for colorectal cancer detection; these samples are 
collected through invasive procedures, the same procedures that are required for 
application of gold standard diagnostic analysis and, therefore, it is unlikely that any 
advantage would be gained by using an animal detector in such applications. In eight 
studies and one condition of a ninth, the testing conditions appear to be feasible for 
relevant operational disease detection and, therefore, provide convincing evidence 
regarding the suitability of animals for the detection of human diseases. 
 
Discussion 
In this review of 28 studies evaluating the use of animal olfaction for detection of 
human diseases, 9 studies used training and testing protocols that appear to be 
operationally viable (see shaded rows in Table 1). The primary reason for a lack of 
operational viability in the remaining studies was the presentation of a fixed number of 
positive samples in runs, which was the case in 19 of the reviewed studies, 14 of which 
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evaluated under conditions that can be arranged in operational settings, and standard 
accuracy measures such as specificity are not informative. 
Although the majority of studies reviewed herein evaluated dogs as cancer 
detectors, only two such studies employed procedures that might work in an operational 
scenario. Amundsen et al. (2014) evaluated dogs as lung cancer detectors using breath 
and urine samples, and Taverna et al. (2015a) examined dogs’ ability to detect prostate 
cancer in urine samples. Although operationally feasible methods appear to have been 
employed in both studies, several key aspects of training and testing conditions were 
unspecified or unclear. Bomers et al. (2012) evaluated  method of C. difficile detection 
in stool samples that appears to be operationally feasible, but did not specify some key 
details of training and testing, such as whether or not testing sample sources differed 
from training sample sources. Hirotsu et al. (2015) used a chemotaxis assay to evaluate 
nematodes’ natural propensity to move toward urine samples from individuals with a 
variety of cancers, finding high sensitivity and specificity. This appears to be an 
operationally viable approach to cancer detection. 
In the four studies evaluating pouched rats as detectors of TB, the research was 
carried out using methods that appear to be operationally viable, although the distribution 
of positive samples throughout runs was not specified in any of the studies (Mahoney et 
al., 2012; Mgode et al., 2012; Reither et al., 2015; Weetjens et al., 2009). The same 
research group has reported results from operational deployment of pouched rats in 
diagnostic algorithms for TB detection in Tanzania and Mozambique, suggesting that 
pouched rats serve a valuable function in this role (Edwards et al., 2016; Mahoney et al., 
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The accuracy of animal detectors of human diseases,  reported in this body of 
literature, varies widely. In Tables 2 and 3, we summarized factors that we consider 
particularly important to successful training and evaluation of disease detection animals. 
Although a quantitative analysis examining the influence of each of these factors on 
accuracy measures would be valuable, current studies have too little in common for such 
an analysis to produce meaningful results. Moreover, relevant information was often 
unreported or undecipherable. 
Many researchers used samples from some untested controls during training and 
testing. Although we described “accurate knowledge of sample status” as a required 
condition for testing, in most cases these untested controls were healthy individuals in 
which the probability of the relevant targeted diseases would be extremely minimal. 
Moreover, testing these individuals with the relevant gold standard diagnostic technology, 
for example by biopsy, would not be possible in many cases. This sample source 
arrangement is only a problem when the set of control sample sources consists 
exclusively, or almost exclusively, of healthy contr ls, in which case the detector may 
simply learn to indicate samples from individuals with health abnormalities. Such 
conditions were arranged in four of the reviewed studies (Buszewski et al., 2012; Horvath 
et al., 2013; McCulloch et al., 2006; Walczak et al., 2012). 
One of the biggest shortcomings of the present body of literature is that much of 
the information related to sample characteristics, raining methods, and evaluation 
procedures was not specified clearly or at all, although some reports were very thorough 
(e.g., Hirotsu et al., 2015; McCulloch et al., 2006). We recommend that authors of future 
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fundamental information that should be included when reporting results. Additionally, 
when space limitations prevent authors from providing sufficient detail to allow others to 
replicate their training and evaluation procedures, they should consider making standard 
operating procedures for training and evaluation avail ble as supplemental information. 
As others have pointed out, there are no standards fo  training disease detection animals 
(e.g., Jezierski et al., 2015; Oh et al., 2015; Walcz k et al., 2012), and the practice of 
sharing procedures may be instrumental in the development of such standards. 
One of the largest threats to the validity of the results from each of these studies is 
the possibility that systematic differences, other t an disease status, between positive and 
control samples in both training and testing phases were responsible for the obtained 
results. An animal trained under such conditions may appear to be a competent detector 
of the targeted disease but is in fact a competent d tector of an irrelevant sample 
characteristic. Although the information that was provided suggests that positive and 
control samples were comparable in at least one conditi  of 22 of the studies, unreported 
differences could have been present in any of the studies in this review. Replications of 
these studies, particularly by different research groups, would add significantly to the 
validity of the findings. 
The small number of positive and control sample sources used in the evaluation 
phases of most studies resulted in imprecise estimates of detection accuracy. Using the 
median positive and control sample source numbers from testing phases and assuming 
that the detector responded correctly to 23 of the 29 positives and 90 of the 116 controls, 
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(69%, 85%), using MedCalc Software (Ostend, Belgium). In this representative example, 
sensitivity has not been established with great precision. 
Some research involving olfactory detection of diseases is not aimed at evaluating 
an operationally viable product. For example, Horvath et al. (2008) were primarily 
interested in determining whether dogs in previous cancer-detection studies were 
responding to VOCs associated directly with cancer or to other associated odors, such as 
metabolic products. This research question shaped their methodology such that it was not 
suitable for evaluation of an operationally viable detection technology. Research with 
animal detectors might also play a key role in the development of electronic, volatile-
detection technology; the operational viability of procedures in this area of research may 
be unimportant. In the present review, however, our aim was to evaluate the potential of 
animal detectors for operational diagnosis of human diseases. 
Olfactory detection of diseases holds the promise of rapid, non-invasive, and cost-
effective diagnosis. At first glance, there appears to be substantial evidence supporting 
the utility of animal detectors in this role. Unfortunately, we have found significant 
limitations associated with this body of research and, with the exception of one 
operationally active research group, animals have not been employed for diagnostic 
purposes in large-scale operational settings. Considering the results obtained using 
methods that we have classified as operationally viable in the present review, we can only 
make tentative conclusions about the potential of anim ls in this role. Under the right 
circumstances, animals appear to be capable of precisely discriminating between samples 
obtained from disease-positive and disease-negative individuals. Programs of research 
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animal detectors are needed.  A major barrier preventing deployment of animal detection 
technology in the medical field is that many of theprocedures used to evaluate animal 
detectors do not translate directly to operations. Therefore, additional research evaluating 
the effectiveness of operationally viable procedures for olfactory detection of diseases is 
also required.  
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Figure Caption 
Figure 1. Cumulative number of studies examining anim l olfactory detection of human 




















































• Guidelines for training and testing disease-detection animals are provided 
• Using these guidelines as points for comparison the relevant literature is reviewed 
• Inconsistent findings have been reported, likely because of procedural differences 
• Some commonly used training and testing procedures are problematic 
• We make recommendations for research and reporting practices in this area 
